What is the primary treatment approach for a patient diagnosed with Stevens-Johnson Syndrome?

The primary treatment approach for a patient diagnosed with Stevens-Johnson Syndrome (SJS) focuses on fluid and electrolyte replacement. SJS is a severe skin reaction that can lead to significant fluid loss, similar to that seen in burn patients. This condition results in widespread skin detachment and mucosal involvement, making patients vulnerable to dehydration and electrolyte imbalances.

In managing SJS, it is crucial to maintain hydration status and replace lost fluids and electrolytes to support overall body function. This often involves intravenous fluids, particularly if the patient is unable to consume adequate oral fluids due to extensive mucosal involvement.

While other treatments may play a role in managing complications or underlying causes—such as using topical steroids for some inflammatory conditions or antiviral medications for specific viral infections—these are not the primary focus in SJS management. Instead, ensuring adequate hydration and monitoring electrolyte levels are fundamental to reducing morbidity and supporting recovery in these patients.